• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与直肠癌综合手术及放疗后局部控制之间的关联。

Association between obesity and local control of advanced rectal cancer after combined surgery and radiotherapy.

作者信息

Choi Yunseon, Lee Yun-Han, Park Sung Kwang, Cho Heunglae, Ahn Ki Jung

机构信息

Department of Radiation Oncology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.

Department of Molecular Medicine, Keimyung University School of Medicine, Daegu, Korea.

出版信息

Radiat Oncol J. 2016 Jun;34(2):113-20. doi: 10.3857/roj.2016.01725. Epub 2016 Jun 17.

DOI:10.3857/roj.2016.01725
PMID:27306771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4938343/
Abstract

PURPOSE

The association between metabolism and cancer has been recently emphasized. This study aimed to find the prognostic significance of obesity in advanced stage rectal cancer patients treated with surgery and radiotherapy (RT).

MATERIALS AND METHODS

We retrospectively reviewed the medical records of 111 patients who were treated with combined surgery and RT for clinical stage 2-3 (T3 or N+) rectal cancer between 2008 and 2014. The prognostic significance of obesity (body mass index [BMI] ≥25 kg/m(2)) in local control was evaluated.

RESULTS

The median follow-up was 31.2 months (range, 4.1 to 85.7 months). Twenty-five patients (22.5%) were classified as obese. Treatment failure occurred in 33 patients (29.7%), including local failures in 13 patients (11.7%), regional lymph node failures in 5, and distant metastases in 24. The 3-year local control, recurrence-free survival, and overall survival rates were 88.7%, 73.6%, and 87.7%, respectively. Obesity (n = 25) significantly reduced the local control rate (p = 0.045; 3-year local control, 76.2%), especially in women (n = 37, p = 0.021). Segregation of local control was best achieved by BMI of 25.6 kg/m(2) as a cutoff value.

CONCLUSION

Obese rectal cancer patients showed poor local control after combined surgery and RT. More effective local treatment strategies for obese patients are warranted.

摘要

目的

新陈代谢与癌症之间的关联最近受到了关注。本研究旨在探讨肥胖在接受手术和放疗(RT)的晚期直肠癌患者中的预后意义。

材料与方法

我们回顾性分析了2008年至2014年间111例接受手术联合RT治疗的临床分期为2-3期(T3或N+)直肠癌患者的病历。评估了肥胖(体重指数[BMI]≥25kg/m²)对局部控制的预后意义。

结果

中位随访时间为31.2个月(范围4.1至85.7个月)。25例患者(22.5%)被归类为肥胖。33例患者(29.7%)出现治疗失败,包括13例局部失败(11.7%)、5例区域淋巴结转移和24例远处转移。3年局部控制率、无复发生存率和总生存率分别为88.7%、73.6%和87.7%。肥胖患者(n = 25)显著降低了局部控制率(p = 0.045;3年局部控制率为76.2%),尤其是女性患者(n = 37,p = 0.021)。以BMI 25.6kg/m²为临界值时,局部控制的区分效果最佳。

结论

肥胖的直肠癌患者在接受手术联合RT后局部控制效果较差。有必要为肥胖患者制定更有效的局部治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3fe/4938343/1462452613f3/roj-2016-01725f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3fe/4938343/f1f6432ea011/roj-2016-01725f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3fe/4938343/7dcafef94318/roj-2016-01725f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3fe/4938343/1462452613f3/roj-2016-01725f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3fe/4938343/f1f6432ea011/roj-2016-01725f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3fe/4938343/7dcafef94318/roj-2016-01725f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3fe/4938343/1462452613f3/roj-2016-01725f3.jpg

相似文献

1
Association between obesity and local control of advanced rectal cancer after combined surgery and radiotherapy.肥胖与直肠癌综合手术及放疗后局部控制之间的关联。
Radiat Oncol J. 2016 Jun;34(2):113-20. doi: 10.3857/roj.2016.01725. Epub 2016 Jun 17.
2
Adverse effect of excess body weight on survival in cervical cancer patients after surgery and radiotherapy.超重对宫颈癌患者术后及放疗后生存的不良影响。
Radiat Oncol J. 2017 Mar;35(1):48-54. doi: 10.3857/roj.2016.01977. Epub 2016 Dec 22.
3
[Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].局部晚期直肠黏液腺癌放疗联合手术的疗效分析:一项基于监测、流行病学和最终结果人群数据的回顾性研究
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):85-93.
4
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
5
Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.降期是否能预测腹膜外局部晚期直肠癌术前放化疗后的预后改善?对165例患者的长期分析。
Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):664-74. doi: 10.1016/s0360-3016(02)02764-5.
6
Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.辅助化疗增强局部晚期淋巴结阳性鼻咽癌的局部控制
Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):261-71. doi: 10.1016/s0360-3016(98)00383-6.
7
Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.鼻咽癌同步局部区域复发的治疗结果
Head Neck. 2003 Jul;25(7):585-94. doi: 10.1002/hed.10242.
8
Impact of body mass index on treatment outcome of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.体重指数对局部晚期直肠癌新辅助放化疗治疗效果的影响。
Eur J Surg Oncol. 2017 Oct;43(10):1828-1834. doi: 10.1016/j.ejso.2017.07.022. Epub 2017 Aug 10.
9
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
10
Local excision and postoperative radiotherapy for distal rectal cancer.低位直肠癌的局部切除及术后放疗
Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1309-16. doi: 10.1016/s0360-3016(01)01545-0.

引用本文的文献

1
Comparing long-term prognosis following different surgical methods in patients with early stage breast cancer and obesity: a retrospective cohort study in China.比较中国早期乳腺癌肥胖患者不同手术方法的长期预后:一项回顾性队列研究。
BMJ Open. 2024 Aug 30;14(8):e078816. doi: 10.1136/bmjopen-2023-078816.
2
Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer.肥胖通过 SERPINE1 介导的三阴性乳腺癌侵袭性和 DNA 修复促进放疗抵抗。
Cell Death Dis. 2023 Jan 21;14(1):53. doi: 10.1038/s41419-023-05576-8.
3
The effect of BMI on long-term outcome in patients with rectal cancer and establishment of a nomogram prediction model.

本文引用的文献

1
Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy.新辅助放化疗后局部晚期直肠癌患者肥胖的肿瘤学及功能危害
Am J Clin Oncol. 2017 Jun;40(3):277-282. doi: 10.1097/COC.0000000000000150.
2
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012.韩国癌症统计数据:2012年的发病率、死亡率、生存率及患病率
Cancer Res Treat. 2015 Apr;47(2):127-41. doi: 10.4143/crt.2015.060. Epub 2015 Mar 3.
3
Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.
BMI 对直肠癌患者长期预后的影响及列线图预测模型的建立。
BMC Gastroenterol. 2023 Jan 9;23(1):5. doi: 10.1186/s12876-023-02638-1.
4
Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy.肥胖可能与局部晚期直肠癌新辅助放化疗后的病理反应无关。
Front Oncol. 2022 Sep 29;12:994444. doi: 10.3389/fonc.2022.994444. eCollection 2022.
5
Radiation-induced Bystander Effect (RIBE) alters mitochondrial metabolism using a human rectal cancer ex vivo explant model.辐射诱导旁观者效应(RIBE)利用人直肠癌离体组织模型改变线粒体代谢。
Transl Oncol. 2021 Jan;14(1):100882. doi: 10.1016/j.tranon.2020.100882. Epub 2020 Oct 23.
6
Development of the 'PREDICT' score through a systematic review and meta-analysis of the predictive parameters for locoregional recurrence after total mesorectal excision.通过对全直肠系膜切除术后局部区域复发预测参数的系统评价和荟萃分析得出“PREDICT”评分。
Updates Surg. 2021 Feb;73(1):35-46. doi: 10.1007/s13304-020-00853-z. Epub 2020 Jul 30.
7
CT-Quantified Adipose Tissue Distribution: Risk or Protective Factor for Complications after Rectal Cancer Surgery?CT 定量脂肪组织分布:直肠癌手术后并发症的风险因素还是保护因素?
Obes Facts. 2019;12(3):259-271. doi: 10.1159/000499320. Epub 2019 May 3.
8
Obesity as an independent predictive factor for pathologic complete response after neoadjuvant chemoradiation in rectal cancer.肥胖作为直肠癌新辅助放化疗后病理完全缓解的独立预测因素。
Ann Surg Treat Res. 2019 Mar;96(3):116-122. doi: 10.4174/astr.2019.96.3.116. Epub 2018 Feb 26.
9
Influence of Obesity on the Course of Malignant Neoplastic Disease in Patients After Pulmonary Metastasectomy.肥胖对肺转移瘤切除术后患者恶性肿瘤病程的影响。
In Vivo. 2018 Jan-Feb;32(1):197-202. doi: 10.21873/invivo.11225.
10
Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer.肌肉减少症与局部晚期直肠癌的长期预后呈负相关。
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):53-59. doi: 10.1002/jcsm.12234. Epub 2017 Aug 28.
成人体重增加与肥胖相关癌症:前瞻性观察研究的剂量反应荟萃分析。
J Natl Cancer Inst. 2015 Mar 10;107(2). doi: 10.1093/jnci/djv088. Print 2015 Feb.
4
Lipid Signaling in Tumorigenesis.肿瘤发生中的脂质信号传导
Mol Cell Pharmacol. 2014 Jan 1;6(1):1-9.
5
Primary and secondary prevention of colorectal cancer.结直肠癌的一级和二级预防。
Clin Med Insights Gastroenterol. 2014 Jul 14;7:33-46. doi: 10.4137/CGast.S14039. eCollection 2014.
6
Obesity was associated with a decreased postoperative recurrence of rectal cancer in a Japanese population.在日本人群中,肥胖与直肠癌术后复发率降低有关。
Surg Today. 2014 Dec;44(12):2324-31. doi: 10.1007/s00595-014-0899-z. Epub 2014 May 21.
7
Targeting mTOR network in colorectal cancer therapy.靶向mTOR网络用于结直肠癌治疗
World J Gastroenterol. 2014 Apr 21;20(15):4178-88. doi: 10.3748/wjg.v20.i15.4178.
8
Cancer as a metabolic disease: implications for novel therapeutics.癌症作为一种代谢疾病:对新型治疗方法的启示。
Carcinogenesis. 2014 Mar;35(3):515-27. doi: 10.1093/carcin/bgt480. Epub 2013 Dec 16.
9
Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway.葡萄糖通过激活 Akt 通路对癌细胞侧群的代谢调控。
Cell Death Differ. 2014 Jan;21(1):124-35. doi: 10.1038/cdd.2013.131. Epub 2013 Oct 4.
10
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.直肠癌:欧洲肿瘤内科学会临床实践指南之诊断、治疗及随访
Ann Oncol. 2013 Oct;24 Suppl 6:vi81-8. doi: 10.1093/annonc/mdt240.